- Home
- PRPH
as 11-14-2024 2:36pm EST
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 14.7M | IPO Year: | 1997 |
| Target Price: | $11.00 | AVG Volume (30 days): | 247.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.66 - $7.48 | Next Earning Date: | 11-13-2024 |
| Revenue: | $12,753,000 | Revenue Growth: | -77.12% |
| Revenue Growth (this year): | 36.93% | Revenue Growth (next year): | 132.05% |
Latest ProPhase Labs Inc. (DE) News
PRPH Breaking Stock News: Dive into PRPH Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
2 days ago
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024
GlobeNewswire
3 days ago
ProPhase Labs Announces Closing of Public Offering of Common Stock
GlobeNewswire
4 days ago
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
MT Newswires
7 days ago
Top Midday Decliners
GlobeNewswire
7 days ago
ProPhase Labs Announces Pricing of Public Offering of Common Stock
GlobeNewswire
8 days ago
ProPhase Labs Announces Proposed Public Offering of Common Stock
GlobeNewswire
11 days ago
ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry
Compare PRPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRPH ProPhase Labs Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.